$10,000 Payout Reference Posted by @ProlongWealth, Bulenox Named
On January 2, 2025, the X account @ProlongWealth published a post that referenced a $10,000 figure tied to tax treatment in funded futures trading, naming Bulenox among a list of prop firms and promoting a discount code for evaluation accounts.
This post is primarily a promotional message advertising a discount code for evaluation accounts and does not document a confirmed individual payout receipt from Bulenox. The $10,000 figure cited refers to a stated K1 tax benefit threshold, not a verified withdrawal.
The post, published on X under the handle @ProlongWealth on January 2, 2025, is primarily a promotional message for The Futures Desk and a discount code, PATHWAY, advertised as offering 30 percent off any evaluation account through January 8, 2025. Within the same message, the author lists features such as daily uncapped payouts, no maximum withdrawal limits, and K1 tax benefits after the first $10,000.
Bulenox appears in the post as part of a list of futures prop firms named alongside Apex Trader Funding, Take Profit, BluSky Trading, Topstep, and My Funded Futures. The post does not state that the $10,000 figure was paid by Bulenox specifically. The reference to $10,000 in the post text relates to a stated K1 tax benefit threshold rather than to a confirmed individual withdrawal from any single firm.
The proof in this form has clear limits. The post does not specify an account size, an instrument traded, a trading strategy, or a duration over which any payout was earned. There is no in-text confirmation that Bulenox processed a payout to @ProlongWealth on this date, and the attached image referenced by the scraper has not been independently verified against a Bulenox payout record in the post body itself.
Readers evaluating this entry should treat it as a dated public reference rather than as a verified Bulenox withdrawal receipt. The value of the post lies in its timestamp, its public attribution to a named handle, and its explicit mention of Bulenox within the active funded futures landscape at the start of 2025. Anything beyond that requires additional documentation that the post itself does not supply.
